Company intelligence / Profile preview

Corin

Cirencester, England, United Kingdomcoringroup.com ↗

Ownership: Private
Employees: ~1258
Development stage: Commercial

Overview

Corin has commercialized a suite of advanced orthopaedic implants and robotic-assisted surgical platforms, including the Apollo™ system for knee procedures. Their technologies are FDA-cleared, EU MDR approved, and AU TGA registered. The company’s clinical results emphasize improved patient-specific outcomes in hip, knee, ankle, and shoulder replacements through AI-driven planning and precision robotics.

Therapeutic areas: Rheumatology
Modalities: DeviceRobotic-assisted surgery platformImplantable medical device (orthopaedic implants)
Industry: Surgical Medical Devices

Drug pipeline

3 assets

ApolloKnee

Commercial

Indications: Knee replacement

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Corin.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corin.

Explore the full profile